159 related articles for article (PubMed ID: 9079677)
21. Water-refined solution structure of the human Grb7-SH2 domain in complex with the erbB2 receptor peptide pY1139.
Pias SC; Johnson DL; Smith DE; Lyons BA
Protein Pept Lett; 2012 Aug; 19(8):832-8. PubMed ID: 22702899
[TBL] [Abstract][Full Text] [Related]
22. Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target.
Watson GM; Lucas WAH; Gunzburg MJ; Wilce JA
Front Mol Biosci; 2017; 4():64. PubMed ID: 29018805
[TBL] [Abstract][Full Text] [Related]
23. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor.
Thömmes K; Lennartsson J; Carlberg M; Rönnstrand L
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):211-6. PubMed ID: 10377264
[TBL] [Abstract][Full Text] [Related]
24. Dimerization in the Grb7 protein.
Peterson TA; Benallie RL; Bradford AM; Pias SC; Yazzie J; Lor SN; Haulsee ZM; Park CK; Johnson DL; Rohrschneider LR; Spuches A; Lyons BA
J Mol Recognit; 2012 Aug; 25(8):427-34. PubMed ID: 22811067
[TBL] [Abstract][Full Text] [Related]
25. Grb7 binds to Hax-1 and undergoes an intramolecular domain association that offers a model for Grb7 regulation.
Siamakpour-Reihani S; Peterson TA; Bradford AM; Argiros HJ; Haas LL; Lor SN; Haulsee ZM; Spuches AM; Johnson DL; Rohrschneider LR; Shuster CB; Lyons BA
J Mol Recognit; 2011; 24(2):314-21. PubMed ID: 20665473
[TBL] [Abstract][Full Text] [Related]
26. Association of Grb7 with phosphoinositides and its role in the regulation of cell migration.
Shen TL; Han DC; Guan JL
J Biol Chem; 2002 Aug; 277(32):29069-77. PubMed ID: 12021278
[TBL] [Abstract][Full Text] [Related]
27. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
28. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
29. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
30. Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand.
Zhang D; Shao C; Hu S; Ma S; Gao Y
PLoS One; 2012; 7(1):e29902. PubMed ID: 22253820
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
[TBL] [Abstract][Full Text] [Related]
32. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
33. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
34. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.
Depetris RS; Hu J; Gimpelevich I; Holt LJ; Daly RJ; Hubbard SR
Mol Cell; 2005 Oct; 20(2):325-33. PubMed ID: 16246733
[TBL] [Abstract][Full Text] [Related]
36. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
[TBL] [Abstract][Full Text] [Related]
37. Structural basis for the interaction of the adaptor protein grb14 with activated ras.
Qamra R; Hubbard SR
PLoS One; 2013; 8(8):e72473. PubMed ID: 23967305
[TBL] [Abstract][Full Text] [Related]
38. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
39. The adaptor Grb7 is a novel calmodulin-binding protein: functional implications of the interaction of calmodulin with Grb7.
Li H; Sánchez-Torres J; del Carpio AF; Nogales-González A; Molina-Ortiz P; Moreno MJ; Török K; Villalobo A
Oncogene; 2005 Jun; 24(26):4206-19. PubMed ID: 15806159
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.
Liu WQ; Vidal M; Olszowy C; Million E; Lenoir C; Dhôtel H; Garbay C
J Med Chem; 2004 Feb; 47(5):1223-33. PubMed ID: 14971902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
